Login / Signup
Katelynn Granger
ORCID
Publication Activity (10 Years)
Years Active: 2023-2023
Publications (10 Years): 1
Top Topics
Ejection Fraction
Prognostic Factors
Diffuse Large B Cell Lymphoma
Multiple Myeloma
Top Venues
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Katelynn Granger
,
Kelly J Gaffney
,
James A Davis
Newly approved and forthcoming T-cell-redirecting bispecific antibodies for the treatment of relapsed/refractory multiple myeloma.
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
(2023)